Metal-Based Drugs: Past, Present and Future
The reprint entitled "Metal-Based Drugs: Past, Present, and Future" covers some recent research and review articles in the field of metal-based drugs used in medicine. By purpose and content, this Book is addressed to the vast number of life science researchers and health care workers (che...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_113888 | ||
| 005 | 20230911 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230911s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-8412-6 | ||
| 020 | |a 9783036584133 | ||
| 020 | |a 9783036584126 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-8412-6 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a GP |2 bicssc | |
| 072 | 7 | |a PN |2 bicssc | |
| 100 | 1 | |a Hangan, Adriana Corina |4 edt | |
| 700 | 1 | |a Lucaciu, Roxana Liana |4 edt | |
| 700 | 1 | |a Hangan, Adriana Corina |4 oth | |
| 700 | 1 | |a Lucaciu, Roxana Liana |4 oth | |
| 245 | 1 | 0 | |a Metal-Based Drugs: Past, Present and Future |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (328 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The reprint entitled "Metal-Based Drugs: Past, Present, and Future" covers some recent research and review articles in the field of metal-based drugs used in medicine. By purpose and content, this Book is addressed to the vast number of life science researchers and health care workers (chemists, pharmacists, biochemists, physicists, and doctors). Our initiative to publish in Molecules Journal the Special Issue entitled "Metal-Based Drugs: Past, Present, and Future" was honored by 13 groups totaling 74 scientists from Asia (India, Saudi Arabia, and Taiwan), Europe (Bulgaria, France, Ireland, Italy, Romania, Spain, Switzerland, and the U.K.), North America (Canada), and Africa (Egypt and South Africa). The number of involved researchers and the geographic distribution of their academic institutions indicate the great interest of the worldwide scientific community in discovering new metal-based drugs that can treat different diseases. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Research & information: general |2 bicssc | |
| 650 | 7 | |a Chemistry |2 bicssc | |
| 653 | |a chlorophyllides | ||
| 653 | |a microarray-based detection | ||
| 653 | |a breast cancer | ||
| 653 | |a MCF-7 | ||
| 653 | |a MDA-MB-231 | ||
| 653 | |a gabapentin | ||
| 653 | |a transition metals | ||
| 653 | |a spectroscopic | ||
| 653 | |a FTIR | ||
| 653 | |a electronic spectra | ||
| 653 | |a TEM | ||
| 653 | |a fluoxetine HCl | ||
| 653 | |a major depressive disorder | ||
| 653 | |a π-acceptor complexes | ||
| 653 | |a molecular docking | ||
| 653 | |a spectroscopy | ||
| 653 | |a chitosan | ||
| 653 | |a cis and trans-Pt(II) | ||
| 653 | |a delivery | ||
| 653 | |a loading efficacy | ||
| 653 | |a thermodynamic analysis | ||
| 653 | |a cancer | ||
| 653 | |a metal complexes | ||
| 653 | |a platinum | ||
| 653 | |a copper | ||
| 653 | |a ruthenium | ||
| 653 | |a Rubus | ||
| 653 | |a zinc oxide | ||
| 653 | |a nanoparticles | ||
| 653 | |a apoptosis | ||
| 653 | |a caspases | ||
| 653 | |a antibacterial activity | ||
| 653 | |a antibiotics | ||
| 653 | |a antimicrobial activity | ||
| 653 | |a green synthesis | ||
| 653 | |a Pseudomonas alloputida | ||
| 653 | |a ROS | ||
| 653 | |a silver | ||
| 653 | |a synergy | ||
| 653 | |a platinum compounds | ||
| 653 | |a gold compounds | ||
| 653 | |a metal-based drugs | ||
| 653 | |a heterobimetallic complexes | ||
| 653 | |a targeting strategies | ||
| 653 | |a ruthenium(II)-arene complexes | ||
| 653 | |a bioorganometallic | ||
| 653 | |a carbohydrates | ||
| 653 | |a CuAAC reactions | ||
| 653 | |a antiparasitic | ||
| 653 | |a Toxoplasma gondii | ||
| 653 | |a human foreskin fibroblasts | ||
| 653 | |a auxotrophy | ||
| 653 | |a toxicity | ||
| 653 | |a gallium | ||
| 653 | |a gold | ||
| 653 | |a lanthanum | ||
| 653 | |a coordination complexes | ||
| 653 | |a oncology | ||
| 653 | |a cancer research | ||
| 653 | |a ruthenium(III) complexes | ||
| 653 | |a anticancer drugs | ||
| 653 | |a liposomes | ||
| 653 | |a serum proteins | ||
| 653 | |a interactions | ||
| 653 | |a platinum (II) complexes | ||
| 653 | |a platinum (IV) complexes | ||
| 653 | |a anticancer agents | ||
| 653 | |a orphan tumors | ||
| 653 | |a resistance phenomena | ||
| 653 | |a copper(II) complexes | ||
| 653 | |a biotin | ||
| 653 | |a anticancer activity | ||
| 653 | |a 3D cell cultures | ||
| 653 | |a NHC silver complexes | ||
| 653 | |a NHCs properties | ||
| 653 | |a structure activity relationships (SAR) | ||
| 653 | |a anti-bacterial compounds | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7729 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/113888 |7 0 |z DOAB: description of the publication |